Skip to content

Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury

Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury (OCEANS-TBI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04073225
Acronym
OCEANS-TBI
Enrollment
23
Registered
2019-08-29
Start date
2020-01-25
Completion date
2024-09-03
Last updated
2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Alzheimers, Military Activity, Traumatic Brain Injury

Keywords

veteran

Brief summary

Patients with a history of traumatic brain injury (TBI) are at elevated risk for Alzheimer's disease and related dementias (ADRD). Improvements in TBI treatment may mitigate this risk. Complex motor activities, which combine physical and cognitive demands, have been shown to have well established neurocognitive benefits. This study seeks to address the need for novel TBI interventions optimized for adults with history of TBI by determining the effectiveness of an immersive computer game designed to integrating complex cognitive-motor interventions.

Detailed description

Patients with a history of traumatic brain injury (TBI) are at elevated risk for Alzheimer's disease and related dementias (ADRD). Improvements in TBI treatment may mitigate this risk. The treatment of TBI, especially for those with chronic neuropsychiatric sequelae, is moving toward multi-modal approaches that include non-pharmacological interventions such as exercise and cognitive enrichment. Complex motor activities, which combine physical and cognitive demands, have been shown to have well established neurocognitive benefits. However, there are a lack of cognitive enhancing interventions that utilize these complex motor activities. Many adults with history of TBI face significant barriers to engaging in physical activity which limit the adults' ability to participate in many neurocognitive interventions. This study seeks to address the need for novel TBI interventions optimized for adults with history of TBI by determining the effectiveness of an immersive computer game designed to integrating complex cognitive-motor interventions. During this proposed 12-month study involving patients with history of TBI (n=66) the investigators will examine cognition, independent function, mood and ADRD related brain biomarkers after 12 weeks of a randomized intervention, as well as 9 months post-intervention to assess for durability of any benefits. The investigators hypothesize that complex motor activities will improve cognitive health in adults with a history of TBI and that promising results would have implications for early intervention for those at risk for Mild Cognitive Impairment and ADRD.

Interventions

DEVICEMindPod Dolphin

The immersive video game being tested in this study is called Bandit the Dolphin, developed by neurologist Dr. John Krakauer, and engineers in the Brain, Learning, Animation, and Movement Lab at Johns Hopkins. Bandit the Dolphin provides an oceanic environment in which the individual's arm movements control a simulated dolphin. The neuromotor effects of this game have been designed to be used in the clinical setting to rehabilitate arm and hand function following stroke. The game has further been modified to a Microsoft Kinect-based system and piloted for play in non-laboratory settings among community-dwelling adults. The game offers a unique combination of skilled arm movements plus varying levels of cognitive challenge. In this way, the individual's arms are challenged the same way the legs would be when walking in a complex, outdoor environment. Importantly, the participant plays while standing, thus engaging the whole body in this novel multi-sensorial experience.

The 10 Keys™ to Healthy Aging Program in an evidence-based program that originated from the University of Pittsburgh Center for Aging and Population Health. This educates and empowers older adults to reach personal goals and help others to so in the community as well. It is designed to teach older adults how to reduce the risk of disease over the aging process by promoting healthy lifestyle changes with the most recent established scientific guidelines. The 10 Keys program also aims to empower individuals to be health ambassadors in the individual's own families and communities, teaching individuals to 'Share the Wealth on Health'. Participants will work towards personal health goal(s) adapted to the participant's lifestyle and abilities.

Sponsors

United States Department of Defense
CollaboratorFED
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English speaking * 40 years of age and older * History of at least one remote TBI (\>3 years ago) of mild and moderate severity as diagnosed by Veteran's Affairs / Department of Defense (VA/DoD) criteria. * Ability to perform most independent activities of daily living without physical assistance (e.g., no canes or walkers because person needs both hands to participate); Chedoke Arm and Hand Activity Inventory - mean score \>5, indicating modified or complete independence in hand and arm functioning. * Ability to dedicate 3 hours per week for about 12 weeks-approximately 20 to 26 hours of total time-to the intervention study. * Ability to give informed consent and understand the tasks involved

Exclusion criteria

* Presence of cognitive impairment based on a Mini-Mental State Exam (MMSE) score ≤ 24. * Presence of diseases associated with gross motor abnormalities that restrict ambulation (e.g., stroke with paresis, multiple sclerosis, amyotrophic lateral sclerosis, cerebellar or spinal cord disorders, peripheral nerve disorders, severe rheumatic or osteoarthritic disorders, limb amputation) * Untreated major mental illness that may preclude successful completion of the study (e.g., major depressive disorder, anxiety disorders, etc.) * History of physical or neurological condition that interferes with study procedures or assessment of motor function (e.g., epilepsy, severe arthritis, severe neuropathy, Parkinson's disease). * Current diagnosis of color blindness. * Social or personal circumstances that interfere with ability to complete 12-14 weeks of training sessions and follow-up evaluation. * Inability to sit in a chair or stand and perform upper limb exercises for one hour at a time.

Design outcomes

Primary

MeasureTime frameDescription
Change in Brain Magnetic Resonance Imaging (MRI) Amygdala Volume (mm3)Baseline, 12 weeksBrain volumetrics will be calculated using a Philips 3 Tesla (T) head-only scanner using established methods. Amygdala volumes were automatically segmented using Freesurfer and were summed across both hemispheres to calculate total volume. Change in total amygdala volume from baseline to 12 weeks was used as the primary measure.
Change in Physical Mobility Outcome as Assessed by the Short Physical Performance BatteryBaseline, 12 weeksThe Short Physical Performance Battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. We measured the change in SPPB score from baseline to 12-week post-intervention follow-up assessments. Total score of 0 to 12, with a higher score indicating better physical function.
Change in Brain Magnetic Resonance Imaging (MRI) Hippocampal Volume (mm3)Baseline, 12 weeksBrain volumetrics will be calculated using a Philips 3 Tesla (T) head-only scanner using established methods. Hippocampal volumes were automatically segmented using Freesurfer and was summed across both hemispheres to calculate total volume. Change in total hippocampal volume from baseline to 12 weeks was used as the primary measure.
Change in Executive Functioning as Assessed by the Trail Making TestBaseline, 12 weeksThe Trail Making Test is a neuropsychological test of visual attention and task switching. It consists of two timed parts (Part A and B) in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy. Our primary measure was the difference in time (seconds) taking to complete Part B subtracted by Part A, which is an indicator of task-switching.
Change in Executive Functioning as Assessed by the Stroop TestBaseline, 12 weeksThe Stroop Test is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect. Our primary measure was the Stroop Effect (i.e., reaction time (milliseconds) for incongruent trials subtracted by reaction time for congruent trials).
Change in Processing Speed Score as Assessed by the Pattern Comparison TestBaseline, 12 weeksThis test measures speed of processing by asking participants to discern whether two side-by-side pictures are the same or not. The processing speed score was the total number of trials completed correctly within the specified time limit.
Change in Verbal Learning as Assessed by the Rey Auditory Verbal Learning Test (RAVLT)Baseline, 12 weeksThe investigators will assess for change in verbal learning using the RAVLT. The RAVLT is a neuropsychological assessment designed to evaluate verbal memory in patients, 16 years of age and older. The RAVLT can be used to evaluate the nature and severity of memory dysfunction and to track changes in memory function over time. The test is designed as a list-learning paradigm in which the patient hears a list of 15 nouns and is asked to recall as many words from the list as possible. Our primary measure was the number of words correctly recalled after a long delay (20 minutes), an indicator of long-term verbal memory.

Secondary

MeasureTime frameDescription
Change in Depressive Symptoms as Assessed by the Patient Health Questionnaire - 9 (PHQ-9)Baseline, 12 weeksThe PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. The PHQ-9 incorporates Diagnostic and Statistical Manual-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool. Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe (total score range of 0-27). Higher score worse/more severe symptoms.
Change in Time (Minutes) Spent Outside Home as Assessed by the Apple Watch GPSBaseline, 12 weeksThe investigators will assess time spent outside the home from an Apple Watch GPS. Time spent out of home is measured by summing total duration spent in latitude/longitude coordinates that fall outside of a 120 meter radial buffer around the participant's home address.

Countries

United States

Participant flow

Recruitment details

Recruitment sources included Johns Hopkins Alzheimer's Disease Research Center (ADRC), Bayview Community Psychiatry Program (CPP), Johns Hopkins Community Physicians (JHCP), JHCP Clinic Champion: advertises study in JHCP, Clinical Connection, ClinicalTrials.gov, ResearchMatch.org, MyChart, and newsletters/flyers.

Participants by arm

ArmCount
MindPod Dolphin Arm
Bandit the Dolphin provides an oceanic environment in which the individual's arm movements control a simulated dolphin. The neuromotor effects of this game have been designed to be used in the clinical setting to rehabilitate arm and hand function following stroke.
14
10 Keys to Healthy Aging
The 10 Keys™ to Healthy Aging Program is designed to teach older adults how to reduce the risk of disease over the aging process by promoting healthy lifestyle changes with the most recent established scientific guidelines.
9
Total23

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up43

Baseline characteristics

Characteristic10 Keys to Healthy AgingTotalMindPod Dolphin Arm
Age, Continuous57.6 years
STANDARD_DEVIATION 13.3
59.3 years
STANDARD_DEVIATION 10.6
60.4 years
STANDARD_DEVIATION 8.9
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants9 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
6 Participants13 Participants7 Participants
Sex: Female, Male
Female
5 Participants10 Participants5 Participants
Sex: Female, Male
Male
4 Participants13 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 9
other
Total, other adverse events
0 / 140 / 9
serious
Total, serious adverse events
0 / 140 / 9

Outcome results

Primary

Change in Brain Magnetic Resonance Imaging (MRI) Amygdala Volume (mm3)

Brain volumetrics will be calculated using a Philips 3 Tesla (T) head-only scanner using established methods. Amygdala volumes were automatically segmented using Freesurfer and were summed across both hemispheres to calculate total volume. Change in total amygdala volume from baseline to 12 weeks was used as the primary measure.

Time frame: Baseline, 12 weeks

Population: Nine participants who had both baseline and 12 week MRI data were included in this analysis.

ArmMeasureValue (MEAN)Dispersion
MindPod Dolphin ArmChange in Brain Magnetic Resonance Imaging (MRI) Amygdala Volume (mm3)67.1 mm3Standard Error 181.1
10 Keys to Healthy AgingChange in Brain Magnetic Resonance Imaging (MRI) Amygdala Volume (mm3)-63.7 mm3Standard Error 148.8
Comparison: We conducted t-tests of differences in volumetric change comparing intervention to control arms.p-value: 0.5995% CI: [-259.7, 248.6]t-test, 2 sided
Primary

Change in Brain Magnetic Resonance Imaging (MRI) Hippocampal Volume (mm3)

Brain volumetrics will be calculated using a Philips 3 Tesla (T) head-only scanner using established methods. Hippocampal volumes were automatically segmented using Freesurfer and was summed across both hemispheres to calculate total volume. Change in total hippocampal volume from baseline to 12 weeks was used as the primary measure.

Time frame: Baseline, 12 weeks

Population: Nine participants who had both baseline and 12 week MRI data were included in this analysis.

ArmMeasureValue (MEAN)Dispersion
MindPod Dolphin ArmChange in Brain Magnetic Resonance Imaging (MRI) Hippocampal Volume (mm3)-109.7 mm^3Standard Error 63.1
10 Keys to Healthy AgingChange in Brain Magnetic Resonance Imaging (MRI) Hippocampal Volume (mm3)-10.3 mm^3Standard Error 192.2
Comparison: We conducted t-tests of differences in volumetric change comparing intervention to control arms.p-value: 0.60595% CI: [-334.3, 533]t-test, 2 sided
Primary

Change in Executive Functioning as Assessed by the Stroop Test

The Stroop Test is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect. Our primary measure was the Stroop Effect (i.e., reaction time (milliseconds) for incongruent trials subtracted by reaction time for congruent trials).

Time frame: Baseline, 12 weeks

Population: One participant was excluded due to missing data at both baseline and 12 week visits.

ArmMeasureValue (MEAN)
MindPod Dolphin ArmChange in Executive Functioning as Assessed by the Stroop Test-49.5 change in milliseconds
10 Keys to Healthy AgingChange in Executive Functioning as Assessed by the Stroop Test31.8 change in milliseconds
Comparison: Mixed effects models were fit including fixed effects for intervention arm, visit (baseline, 12 week) and intervention by visit interaction; and random intercepts and slopes for each participant.p-value: 0.05795% CI: [-165.2, 2.5]Mixed Models Analysis
Primary

Change in Executive Functioning as Assessed by the Trail Making Test

The Trail Making Test is a neuropsychological test of visual attention and task switching. It consists of two timed parts (Part A and B) in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy. Our primary measure was the difference in time (seconds) taking to complete Part B subtracted by Part A, which is an indicator of task-switching.

Time frame: Baseline, 12 weeks

Population: One participant was excluded due to missing data at both baseline and 12 week visits.

ArmMeasureValue (MEAN)
MindPod Dolphin ArmChange in Executive Functioning as Assessed by the Trail Making Test-9.2 change in seconds
10 Keys to Healthy AgingChange in Executive Functioning as Assessed by the Trail Making Test24.7 change in seconds
Comparison: Mixed effects models were fit including fixed effects for intervention arm, visit (baseline, 12 week) and intervention by visit interaction; and random intercepts and slopes for each participant.p-value: 0.32395% CI: [-100.9, 33.2]Mixed Models Analysis
Primary

Change in Physical Mobility Outcome as Assessed by the Short Physical Performance Battery

The Short Physical Performance Battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. We measured the change in SPPB score from baseline to 12-week post-intervention follow-up assessments. Total score of 0 to 12, with a higher score indicating better physical function.

Time frame: Baseline, 12 weeks

Population: There were 10 intervention participants and 6 control group participants that had data collected at both baseline and post-intervention 12-week follow-up assessments.

ArmMeasureValue (MEAN)Dispersion
MindPod Dolphin ArmChange in Physical Mobility Outcome as Assessed by the Short Physical Performance Battery0.67 score on a scaleStandard Deviation 1.03
10 Keys to Healthy AgingChange in Physical Mobility Outcome as Assessed by the Short Physical Performance Battery-0.60 score on a scaleStandard Deviation 1.83
p-value: 0.14795% CI: [-0.5, 3.03]t-test, 2 sided
Primary

Change in Processing Speed Score as Assessed by the Pattern Comparison Test

This test measures speed of processing by asking participants to discern whether two side-by-side pictures are the same or not. The processing speed score was the total number of trials completed correctly within the specified time limit.

Time frame: Baseline, 12 weeks

Population: One participant was excluded due to missing data at both baseline and 12 week visits.

ArmMeasureValue (MEAN)
MindPod Dolphin ArmChange in Processing Speed Score as Assessed by the Pattern Comparison Test2.0 trials
10 Keys to Healthy AgingChange in Processing Speed Score as Assessed by the Pattern Comparison Test-1.0 trials
Comparison: Mixed effects models were fit including fixed effects for intervention arm, visit (baseline, 12 week) and intervention by visit interaction; and random intercepts and slopes for each participant.p-value: 0.04795% CI: [0.03, 6.08]Mixed Models Analysis
Primary

Change in Verbal Learning as Assessed by the Rey Auditory Verbal Learning Test (RAVLT)

The investigators will assess for change in verbal learning using the RAVLT. The RAVLT is a neuropsychological assessment designed to evaluate verbal memory in patients, 16 years of age and older. The RAVLT can be used to evaluate the nature and severity of memory dysfunction and to track changes in memory function over time. The test is designed as a list-learning paradigm in which the patient hears a list of 15 nouns and is asked to recall as many words from the list as possible. Our primary measure was the number of words correctly recalled after a long delay (20 minutes), an indicator of long-term verbal memory.

Time frame: Baseline, 12 weeks

Population: One participant was excluded due to missing data at both baseline and 12 week visits.

ArmMeasureValue (MEAN)
MindPod Dolphin ArmChange in Verbal Learning as Assessed by the Rey Auditory Verbal Learning Test (RAVLT)1.5 words
10 Keys to Healthy AgingChange in Verbal Learning as Assessed by the Rey Auditory Verbal Learning Test (RAVLT)0.9 words
Comparison: Mixed effects models were fit including fixed effects for intervention arm, visit (baseline, 12 week) and intervention by visit interaction; and random intercepts and slopes for each participant.p-value: 0.56595% CI: [-1.4, 2.6]Mixed Models Analysis
Secondary

Change in Depressive Symptoms as Assessed by the Patient Health Questionnaire - 9 (PHQ-9)

The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. The PHQ-9 incorporates Diagnostic and Statistical Manual-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool. Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe (total score range of 0-27). Higher score worse/more severe symptoms.

Time frame: Baseline, 12 weeks

Population: There were 10 intervention and 4 control group participants with available data for PHQ-9 at both baseline and 12-week post-intervention assessments.

ArmMeasureValue (MEAN)Dispersion
MindPod Dolphin ArmChange in Depressive Symptoms as Assessed by the Patient Health Questionnaire - 9 (PHQ-9)0.10 score on a scaleStandard Deviation 4.72
10 Keys to Healthy AgingChange in Depressive Symptoms as Assessed by the Patient Health Questionnaire - 9 (PHQ-9)-1 score on a scaleStandard Deviation 6.68
p-value: 0.73195% CI: [-7.91, 5.71]t-test, 2 sided
Secondary

Change in Time (Minutes) Spent Outside Home as Assessed by the Apple Watch GPS

The investigators will assess time spent outside the home from an Apple Watch GPS. Time spent out of home is measured by summing total duration spent in latitude/longitude coordinates that fall outside of a 120 meter radial buffer around the participant's home address.

Time frame: Baseline, 12 weeks

Population: There were 10 intervention group participants and 6 control group participants that had data collected for time spent outside of home at both baseline and 12-week post-intervention assessments.

ArmMeasureValue (MEAN)Dispersion
MindPod Dolphin ArmChange in Time (Minutes) Spent Outside Home as Assessed by the Apple Watch GPS59.99 minutesStandard Deviation 172.65
10 Keys to Healthy AgingChange in Time (Minutes) Spent Outside Home as Assessed by the Apple Watch GPS35.27 minutesStandard Deviation 60.09
p-value: 0.74395% CI: [-183.11, 133.68]t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026